Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 May;17(5):273-277.
doi: 10.1200/OP.20.01070.

Building Toward Antiracist Cancer Research and Practice: The Case of Precision Medicine

Jacob N Stein  1   2 , Marjory Charlot  1 , Samuel Cykert  3
Affiliations
Editorial

Building Toward Antiracist Cancer Research and Practice: The Case of Precision Medicine

Jacob N Stein et al. JCO Oncol Pract. 2021 May.
No abstract available

PubMed Disclaimer

References

    1. Costa PA, Saul EE, Paul Y, et al. . Prevalence of targetable mutations in Black patients with lung cancer: A systematic review and meta-analysis. J Oncol Pract 17:e629-e636, 2021 - PubMed
    1. O'Neill WQ, Wasman J, Thuener J, et al. . African Americans with p16+ and p16− oropharyngeal squamous cell carcinomas have distinctly poor treatment outcomes independent of medical care access. J Oncol Pract 17:e695-e702, 2021 - PMC - PubMed
    1. Yang S-R, Schultheis AM, Yu H, et al. : Precision medicine in non-small cell lung cancer: Current applications and future directions. Semin Cancer Biol doi:10.1016/j.semcancer.2020.07.009 [epub ahead of print on July 27, 2020] - DOI - PubMed
    1. Howlader N, Forjaz G, Mooradian MJ, et al. : The effect of advances in lung-cancer treatment on population mortality. N Engl J Med 383:640-649, 2020 - PMC - PubMed
    1. Soria J-C, Ohe Y, Vansteenkiste J, et al. : Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med 378:113-125, 2018 - PubMed

Publication types